Christopher Zajac

This study uses CRISPR-activation to identify genes with fitness effects in Candida albicans isolates, revealing resistance genes and vulnerabilities associated with copy number variants.

This study analyzes genomic variation in serial Candida albicans isolates from patients, identifying aneuploidy, polyploidy, and loss of heterozygosity as factors driving antifungal drug tolerance.

This study analyzes Candida bloodstream isolates from multiple hospitals, identifying species distribution, antifungal resistance patterns, and within-patient variability in drug susceptibility.